Bone Biologics BBLG Q1 2026 earnings
Reported May 14, 2026 · After market close
EPS estimate-$0.43
Next report
Aug 13, 2026 (in a month)EPS estimate-$0.39
Versus estimates
Ask the moment Bone Biologics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Bone Biologics report Q1 2026 earnings?
- Bone Biologics (BBLG) reported Q1 2026 earnings on May 14, 2026 after market close.
- What were Bone Biologics's Q1 2026 revenue and EPS?
- Bone Biologics reported diluted EPS of $-0.43 for Q1 2026.
- Did Bone Biologics beat estimates in Q1 2026?
- EPS beat the consensus estimate of $-0.43 by $0.00.
- How did Bone Biologics's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, diluted EPS grew 77.6% from $-1.92.
- Where can I find Bone Biologics's Q1 2026 SEC filings?
- You can read the 10-Q periodic report (0001493152-26-023163) directly on SEC EDGAR. The filing index links above go to sec.gov.